Calcium in PDB 7bh8: 3H4-Fab Hla-E-VL9 Co-Complex

The structure of 3H4-Fab Hla-E-VL9 Co-Complex, PDB code: 7bh8 was solved by L.C.Walters, D.Rozbesky, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	54.74 / 1.80
Space group	C 1 2 1
Cell size a, b, c (Å), α, β, γ (°)	190.433, 73.695, 159.727, 90, 101.63, 90
R / Rfree (%)	19.5 / 23.2

The binding sites of Calcium atom in the 3H4-Fab Hla-E-VL9 Co-Complex (pdb code 7bh8). This binding sites where shown within 5.0 Angstroms radius around Calcium atom.
In total only one binding site of Calcium was determined in the 3H4-Fab Hla-E-VL9 Co-Complex, PDB code: 7bh8:

Calcium binding site 1 out of 1 in the 3H4-Fab Hla-E-VL9 Co-Complex


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 1 of 3H4-Fab Hla-E-VL9 Co-Complex within 5.0Å range: probe atom residue distance (Å) B Occ G:Ca302 b:63.3 occ:1.00 O G:SER100 3.0 39.9 1.0 O G:GLY100C 3.1 33.2 1.0 O H:HOH473 3.1 35.4 1.0 N G:TYR98 3.3 34.2 1.0 O G:TYR98 3.3 39.7 1.0 CE2 H:TYR91 3.5 27.9 1.0 CB G:TYR97 3.5 33.8 1.0 O G:HOH552 3.6 35.1 1.0 CA G:TYR97 3.7 39.1 1.0 C G:TYR98 4.0 30.6 1.0 C G:TYR97 4.0 36.4 1.0 C G:GLY100C 4.0 30.2 1.0 CD2 H:TYR91 4.1 28.2 1.0 C G:SER100 4.2 37.8 1.0 CA G:TYR98 4.2 37.0 1.0 CE1 H:TYR32 4.3 33.7 1.0 CD1 H:TYR32 4.5 28.3 1.0 CZ H:TYR91 4.6 28.0 1.0 CA G:TRP100D 4.7 23.8 1.0 CG G:TYR97 4.7 43.0 1.0 OH H:TYR91 4.7 32.0 1.0 N G:TRP100D 4.8 29.5 1.0 CB G:TYR98 4.8 37.5 1.0 N G:SER100 4.8 35.5 1.0 CD2 G:TYR97 4.9 43.4 1.0 N G:GLY100C 5.0 27.5 1.0 O G:HOH571 5.0 43.8 1.0 CA G:GLY100C 5.0 28.5 1.0

D.Li, S.Brackenridge, L.C.Walters, O.Swanson, K.Harlos, D.Rozbesky, D.W.Cain, K.Wiehe, R.M.Scearce, M.Barr, Z.Mu, R.Parks, M.Quastel, R.J.Edwards, Y.Wang, W.Rountree, K.O.Saunders, G.Ferrari, P.Borrow, E.Y.Jones, S.M.Alam, M.L.Azoitei, G.M.Gillespie, A.J.Mcmichael, B.F.Haynes. Mouse and Human Antibodies Bind Hla-E-Leader Peptide Complexes and Enhance Nk Cell Cytotoxicity. Commun Biol V. 5 271 2022.
ISSN: ESSN 2399-3642
PubMed: 35347236
DOI: 10.1038/S42003-022-03183-5